Skip to main content
Watch Insiders

Corporate insider profile

Claire Mazumdar Insider Trades

Latest reported as Chief Executive Officer of Bicara Therapeutics Inc. (BCAX).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,218,672.50
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

BCAXLatest reported

Bicara Therapeutics Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale10,000$27.98$279,750
Jul 10, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale10,000$28.42$284,198
May 18, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale15,000$20.04$300,579
Apr 20, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale15,000$23.61$354,146